Literature DB >> 20041967

Myelodysplastic syndrome in elderly patients: correlation of CBC with cytogenetic and FISH analysis.

K-E T Codispoti1, L Depalma.   

Abstract

Unexplained anemia in the elderly could represent myelodysplastic syndrome (MDS). We assessed the utility of using a fluorescence in situ hybridization (FISH) panel for common chromosomal abnormalities seen in MDS. A total of 101 elderly outpatients with anemia of unknown etiology were evaluated. Complete blood count, bone marrow biopsy, conventional cytogenetic analysis (CC), and FISH panel were reviewed. A total of 21 (21%) of the 101 patients had MDS. A combination of CC and FISH identified chromosomal abnormalities in 17 (81%) of the patients with MDS. The remaining 4 (19%) were diagnosed with MDS based solely on morphologic criteria. Except in two cases, FISH did not reveal abnormalities not already detected by CC. Furthermore, MDS patients infrequently had isolated anemia (14%) as opposed to those without MDS (75%). A MDS FISH panel is not more sensitive than CC in elderly outpatients with unexplained anemia. MDS is more likely if in addition to anemia, leukopenia and/or thrombocytopenia are also present.

Entities:  

Mesh:

Year:  2009        PMID: 20041967      PMCID: PMC2897924          DOI: 10.1111/j.1751-553X.2009.01210.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  17 in total

1.  Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.

Authors:  Francesc Solé; Elisa Luño; Carmen Sanzo; Blanca Espinet; Guillermo F Sanz; José Cervera; María José Calasanz; Juan Cruz Cigudosa; Fuensanta Millà; Josep Maria Ribera; Encarna Bureo; Maria Luisa Marquez; Eva Arranz; Lourdes Florensa
Journal:  Haematologica       Date:  2005-09       Impact factor: 9.941

2.  Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.

Authors:  G M Rigolin; R Bigoni; R Milani; F Cavazzini; M G Roberti; A Bardi; P Agostini; M Della Porta; A Tieghi; N Piva; A Cuneo; G Castoldi
Journal:  Leukemia       Date:  2001-12       Impact factor: 11.528

Review 3.  Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.

Authors:  David P Steensma; Alan F List
Journal:  Mayo Clin Proc       Date:  2005-05       Impact factor: 7.616

4.  Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys.

Authors:  Mikkael A Sekeres; W Marieke Schoonen; Hagop Kantarjian; Alan List; Jon Fryzek; Ronald Paquette; Jaroslaw P Maciejewski
Journal:  J Natl Cancer Inst       Date:  2008-10-28       Impact factor: 13.506

5.  Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?

Authors:  David P Steensma; Gordon W Dewald; Janice M Hodnefield; Ayalew Tefferi; Curtis A Hanson
Journal:  Leuk Res       Date:  2003-03       Impact factor: 3.156

6.  Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients.

Authors:  P Bernasconi; P M Cavigliano; M Boni; S Calatroni; C Klersy; I Giardini; B Rocca; N Crosetto; M Caresana; M Lazzarino; C Bernasconi
Journal:  Leukemia       Date:  2003-11       Impact factor: 11.528

7.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia.

Authors:  Jack M Guralnik; Richard S Eisenstaedt; Luigi Ferrucci; Harvey G Klein; Richard C Woodman
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

Review 8.  Strategies for the laboratory diagnosis of some common causes of anaemia in elderly patients.

Authors:  Etienne Joosten
Journal:  Gerontology       Date:  2004 Mar-Apr       Impact factor: 5.140

9.  Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study.

Authors:  Athena M Cherry; Stephanie R Brockman; Sarah F Paternoster; Gary A Hicks; Donna Neuberg; Rodney R Higgins; John M Bennett; Peter L Greenberg; Kenneth Miller; Martin S Tallman; Jacob Rowe; Gordon W Dewald
Journal:  Leuk Res       Date:  2003-12       Impact factor: 3.156

10.  Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients.

Authors:  Maura Romeo; Maria de Lourdes Chauffaille; Maria Regina R Silva; Daniella M M Bahia; José Kerbauy
Journal:  Leuk Res       Date:  2002-11       Impact factor: 3.156

View more
  2 in total

1.  Prognostic factors in myelodysplastic syndromes.

Authors:  Irina Triantafyllidis; Anca Ciobanu; Oana Stanca; Anca Roxana Lupu
Journal:  Maedica (Buchar)       Date:  2012-12

2.  Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes.

Authors:  Tatjana Sotirova; Aleksandar Stojanovic; Sonja Genadieva-Stavric; Svetlana Krstevska; Dejan Spasovski; Trajan Balkanov
Journal:  Mater Sociomed       Date:  2014-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.